Search Results - "Alberti, C"

Prostate cancer: radioresistance molecular target-related markers and foreseeable modalities of radiosensitization by Alberti, C

“…Though the external beam radiation therapy is a standard treatment option for both organ-confined and regionally advanced prostate cancer, unluckily, despite…”
Get more information

From molecular imaging in preclinical/clinical oncology to theranostic applications in targeted tumor therapy by Alberti, C

“…The impact of constantly developing molecular sciences on the various imaging modalities (particularly nuclear, magnetic resonance-based, optical techniques)…”
Get more information

Optimization of Initial Tacrolimus Dose Using Pharmacogenetic Testing by Thervet, E, Loriot, M A, Barbier, S, Buchler, M, Ficheux, M, Choukroun, G, Toupance, O, Touchard, G, Alberti, C, Le Pogamp, P, Moulin, B, Le Meur, Y, Heng, A E, Subra, J F, Beaune, P, Legendre, C

“…Retrospective studies have demonstrated that patients who are expressors of cytochrome P4503A5 (CYP3A5) require a higher tacrolimus dose to achieve a…”
Get full text

Ligand-dependent EGFR activation induces the co-expression of IL-6 and PAI-1 via the NFkB pathway in advanced-stage epithelial ovarian cancer by Alberti, C, Pinciroli, P, Valeri, B, Ferri, R, Ditto, A, Umezawa, K, Sensi, M, Canevari, S, Tomassetti, A

“…The epidermal growth factor receptor (EGFR), a member of the ErbB family of receptor tyrosine kinases, is expressed in up to 70% of epithelial ovarian cancers…”
Get full text

Congenital ureteropelvic junction obstruction: physiopathology, decoupling of tout court pelvic dilatation-obstruction semantic connection, biomarkers to predict renal damage evolution by Alberti, C

“…The widespread use of fetal ultrasonography results in a frequent antenatally observation of hydronephrosis, ureteropelvic junction obstruction (UPJO)…”
Get more information

About a case of unilateral perirenal retroperitoneal fibrosis without aorta involvement by Alberti, C

Get more information

Prostate cancer immunotherapy, particularly in combination with androgen deprivation or radiation treatment. Customized pharmacogenomic approaches to overcome immunotherapy cancer resistance by Alberti, C

“…Conventional therapeutic approaches for advanced prostate cancer - such as androgen deprivation, chemotherapy, radiation - come up often against lack of…”
Get full text

Tissue engineering as innovative chance for organ replacement in radical tumor surgery by Alberti, C

“…Different pathological conditions such as congenital organ absence, severe organ injuries, end-stage organ failure and malignancy-related organ removal, have…”
Get more information

Pre-radiotherapy identification of individual genomic profile to avoid, by resort to customized radiosensitizers, the risk of radioresistance development in patients with localized prostate cancer by Alberti, C

Get full text

DNA-binding mechanism and evolution of replication protein A by Madru, Clément, Martínez-Carranza, Markel, Laurent, Sébastien, Alberti, Alessandra C., Chevreuil, Maelenn, Raynal, Bertrand, Haouz, Ahmed, Le Meur, Rémy A., Delarue, Marc, Henneke, Ghislaine, Flament, Didier, Krupovic, Mart, Legrand, Pierre, Sauguet, Ludovic

“…Replication Protein A (RPA) is a heterotrimeric single stranded DNA-binding protein with essential roles in DNA replication, recombination and repair. Little…”
Get full text

Revisiting the retroperitoneal fibroses: are there any significant news about their aetiopathogenesis and diagnostic approaches? by Alberti, C

“…Many articles on retroperitoneal fibroses (RPFs), published over the last ten years, seem to set out as innovative the carried-out both diagnostic procedures…”
Get more information

Drug-induced retroperitoneal fibrosis: short aetiopathogenetic note, from the past times of ergot-derivatives large use to currently applied bio-pharmacology by Alberti, C

“…Among the secondary forms of retroperitoneal fibrosis (RPF), that drug-induced shows very intriguing aspects given both the broad range of involved…”
Get full text

Biometry of the Corpus Callosum in Children: MR Imaging Reference Data by GAREL, C, CONT, I, ALBERTI, C, JOSSERAND, E, MOUTARD, M. L, DUCOU LE POINTE, H

“…The availability of data relating to the biometry of the CC in children that are easy to use in daily practice is limited. We present a reference biometry of…”
Get full text

Kidney Transplant Recipients Carrying the CYP3A422 Allelic Variant Have Reduced Tacrolimus Clearance and Often Reach Supratherapeutic Tacrolimus Concentrations by Pallet, N., Jannot, A.‐S., El Bahri, M., Etienne, I., Buchler, M., de Ligny, B. H., Choukroun, G., Colosio, C., Thierry, A., Vigneau, C., Moulin, B., Le Meur, Y., Heng, A.‐E., Subra, J.‐F., Legendre, C., Beaune, P., Alberti, C., Loriot, M. A., Thervet, E.

“…CYP3A4*22 is an allelic variant of the cytochrome P450 3A4 associated with a decreased activity. Carriers of this polymorphism may require reduced tacrolimus…”
Get full text

Whyever bladder tissue engineering clinical applications still remain unusual even though many intriguing technological advances have been reached? by Alberti, C

“…To prevent problematic outcomes of bowel-based bladder reconstructive surgery, such as prosthetic tumors and systemic metabolic complications, research works,…”
Get full text

Neuroendocrine differentiation in prostate carcinoma: focusing on its pathophysiologic mechanisms and pathological features by Alberti, C

“…Neuroendocrine differentiation in prostate carcinoma: focusing on its pathophysiologic mechanisms and pathological features. C. Alberti Prostate carcinoma,…”
Get full text

Some marginal considerations about both preventive and therapeutic measures towards intestinal fibrosis in IBD by Alberti, C

Get more information

Why do not widen the use of Acoustic Radial Force Impulse method to staging assessment of the retroperitoneal fibrosis? by Alberti, C

Get more information

Predictors of response to infliximab in paediatric perianal Crohn's disease by Dupont‐Lucas, C., Dabadie, A., Alberti, C., Ruemmele, F. M.

“…Summary Background It is reported that 27–54% of paediatric patients with perianal Crohn's disease (CD) do not respond to infliximab (IFX). Aim To identify…”
Get full text

Taxane- and epothilone-based chemotherapy: from molecule cargo cytoskeletal logistics to management of castration-resistant prostate carcinoma by Alberti, C

“…Challenges in the discovery of more potent agents to treat the castration-resistant prostate carcinoma (CRPC) reflect the frustrating condition due to…”
Get more information